Result Summary for ARI40013

Result Summary
Protocol ID: ARI40013
Clinical Study ID: ARI40013
Official Title: GI 198745 in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH): An Open, Multicentre, Phase IIIb Study.
Phase: Phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations: